A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

NCT00802594 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Trypanosomiasis, African

Interventions

DRUG: DB289

Sponsor

Immtech Pharmaceuticals, Inc

Collaborators

[object Object]